Beractant (Survanta)

Photograph of Beractant under the microscope.

Beractant is used primarily for the prevention and treatment of Respiratory Distress Syndrome (RDS) in premature infants. It is often given within 15 minutes of birth in a life-saving effort. Beractant acts to lower the surface tension on alveolar surfaces during respiration, replenishes surfactant and restores surface activity to the lungs of these infants. This drug should be used with caution and only under the watchful eye of qualified physicians in a hospital setting.

© 1995-2022 by Michael W. Davidson and The Florida State University. All Rights Reserved. No images, graphics, software, scripts, or applets may be reproduced or used in any manner without permission from the copyright holders. Use of this website means you agree to all of the Legal Terms and Conditions set forth by the owners.
This website is maintained by our
Graphics & Web Programming Team
in collaboration with Optical Microscopy at the
National High Magnetic Field Laboratory.
Last modification: Monday, Jul 02, 2018 at 04:22 PM
Access Count Since March 28, 1998: 46768